Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. Her PhD research focused on occupational exposures and head and neck cancer. 



She then joined the UMQVC at the University hospital of Besancon where she provides methodological support for clinicians in designing, analyzing and promoting results from clinical research. She is particularly involved into research on breast cancer or gynecologic cancers. She is statistical editor among the Cochrane Lung Cancer Group. She also provides lessons in biostatistics to medical school students and in research methodology to public health master’s degree students. Since 2017, she is the head of the module "Monitoring of HRQoL in clincial practice".

Main areas of expertise

  • Epidemiology
  • Clinical trials and clinical research
  • Biostatistics
  • Oncology
  • Meta-analyses and Cochrane methodology
  • Occupational epidemiology


Main ongoing external collaboration

- Cochrane Lung Cancer Group


Latest publications

sample

Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY,
Journal name : Cancer Medecine

sample

ABSTRACTPurpose Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III...

Posted by : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Journal name : Journal of Clinical Oncology

sample

AbstractBackground:Frailty is highly prevalent in elderly people. While significant progress has been made to...

Posted by : Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Dr. Sophie PAGET-BAILLY, Mme. Audrey FOUBERT, Mme. Astrid POZET, Pr. Franck BONNETAIN
Journal name : BMC Geriatrics

sample

ABSTRACTBackground: Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side...

Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : The Breast

sample

The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...

Posted by : Pr. Franck BONNETAIN, Dr. Guillaume MOUILLET, Mme. Joëlle FRITZSCH, Dr. Sophie PAGET-BAILLY, Mme. Ikram ES-SAAD
Journal name : La revue de l'infirmière

sample

AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : European Journal of Cancer

sample

AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Dr. Amélie ANOTA, ,
Journal name : Expert Review of Anticancer Therapy

sample

AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : Breast Cancer Research

sample

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Dr. Amélie ANOTA
Journal name : PlosOne

sample

AbstractBackgroundWe studied the relationship between intermediate criteria and overall survival (OS) in metastatic...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY
Journal name : Clinical Colorectal Cancer

Latest News

Latest tools

The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY

Discover Pr Bonnetain's keynote during the canceropôle IDF' seminar on rare tumours.Listen to the keynote here.Discover...

Posted by : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN

Posted by : Mme. Astrid POZET, Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET, Dr. Amélie ANOTA, Dr. Sophie PAGET-BAILLY

Posted by : Dr. Sophie PAGET-BAILLY

On Friday 17 November, the Quality of Life in Cancer conference, organized by the UMQVC with the support of the Pôle de...

Posted by : Dr. Sophie PAGET-BAILLY, Mr. Ahmad OUSMEN, Dr. Guillaume MOUILLET, Mme. Joëlle FRITZSCH, Mme. Emilie CHARTON, Dr. Amélie ANOTA

2015-2018 © Copyright - UMQVC.org

Website by Pearlweb